Claret Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Claret Asset Management's LLY Position: Q2 2026 in Review
Claret Asset Management held its Eli Lilly (LLY) position steady in Q2 2026 at 318 shares worth $382K. The position accounts for 0.04% of the portfolio, ranked #130.
Claret Asset Management first reported a position in LLY in Q4 2017 and has held it in 22 quarters since. The position peaked at $3.9M in Q4 2019. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Claret Asset Management held 318 shares of Eli Lilly worth $382K as of Q2 2026.
- Claret Asset Management left its Eli Lilly share count unchanged in Q2 2026.
- Eli Lilly made up 0.04% of Claret Asset Management's portfolio in Q2 2026, its #130 holding.
- Claret Asset Management first reported a position in Eli Lilly in Q4 2017 and has held it in 22 quarters since.
- Claret Asset Management's Eli Lilly position peaked at $3.9M in Q4 2019.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.